MGCA post

06/10/2024Friday, May 10th, 2024Tuesday, February 13th, 2024Wednesday, January 17th, 2024Thursday, November 16th, 2023Wednesday, September 20, 2023Thursday, May 25, 2023
Full Name*
Email*
example@example.com
Institution
Degrees
a. Direct blocking of ACh receptorb. Reduced number of receptors mediated by internalization and degradation of receptorsc. Deposit of complement and secondary destruction of muscle membraned. All of the above
a. Prednisoneb. Plasma Exchangec. FcRn Blockersd. Both b and c
a. Ageb. Severity of MGc. Duration of MGd. Sexe. None of the above
a. Most patients with MG do not respond to FcRn inhibitor therapy until 3 months after treatment startsb. Many patients with MG are intolerant of FcRn inhibitor therapyc. About 40% of patients with MG achieve minimal manifestations status after the first 4-week cycle of infusionsd. Both a and b
Should be Empty: